Top Stories
Duke’s biobanks will give Network Bio access to patient samples linked to years of clinical records, helping train AI models for drug discovery and disease detection.
Eli Lilly's two GLP-1 offerings Zepbound (tirzepatide) and Foundayo (orforglipron) will be available via Hims & Hers' consumer platform.
Researchers developed an AI system that uses smartwatch sensors to passively detect hypertension, without cuff calibration.
The deal adds to the Swiss drugmaker's growing AI push, which includes plans for autonomous R&D labs and a search for a global head of AI for drug discovery.
More than 20,000 patients with persistent bloating or abdominal discomfort will take part in the trial to see whether blood tests can help doctors determine who needs urgent cancer investigations.
Conference News
Head-to-head study demonstrated better identification of treatment-eligible MASH patients while reducing uncertainty in fibrosis staging compared with ELFDENVER, CO / ACCESS Newswire / November 6, 202...
Biologically grounded AI models decode tissue complexity to uncover shared disease drivers across autoimmune indicationsWALTHAM, Mass.--(BUSINESS WIRE)-- BostonGene, developer of an AI model for tumor...
Leveraging over 50 years of expertise in enzymology, NEB® shares insights on reagents and workflows for molecular diagnostics, including cfDNA & cfRNA analysis, enzymatic methylation profiling, and hi...
New Category Will Introduce a Closed-Loop Framework: Predict. Perform. Recover. Keeping the Surgeon's Expertise and Control at the Center of the ORDALLAS, Nov. 6, 2026 /PRNewswire/ -- Zimmer Biomet Ho...
Studies from Beth Israel Deaconess and the University of Colorado highlight how AI-ECG can help clinicians identify suspected cardiac disease from routine ECGsSAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, ...
